HARMONY BIOSCIENCES HOLDINGS, INC. (HRMY) Return on equity 2020–2025
HARMONY BIOSCIENCES HOLDINGS, INC. (HRMY) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
18.2%FY2025 · since FY2020: -38.0% → 18.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 18.2% | -3.8 pp |
| FY2024 | 22.1% | -5.5 pp |
| FY2023 | 27.6% | -17.5 pp |
| FY2022 | 45.0% | +26.5 pp |
| FY2021 | 18.5% | +56.6 pp |
| FY2020 | -38.0% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More HRMY financial trends
HRMY RevenueHRMY Net incomeHRMY Net marginHRMY Gross profitHRMY Gross marginHRMY Operating incomeHRMY Operating marginHRMY Operating cash flowHRMY Free cash flowHRMY Capital expendituresHRMY Stock buybacksHRMY Dividends paidHRMY Total assetsHRMY Total liabilitiesHRMY Shareholders’ equityHRMY overview →